A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. - Kragballe,K.; Austad,J.; Barnes,L.; Bibby,A.; de la Brassinne,M.; Cambazard,F.; Fleming,C.; Heikkila,H.; Jolliffe,D.; Peyri,J.; Svensson,A.; Toole,J.; et al. (Br J Dermatol, 2006)